Total Absorbed Doses in Different Organs (mGy/MBq) after Application of 177Lu-PSMA I&T, Calculated by Both Methods
| Total absorbed dose (mGy/MBq) | ||
| Target organ | M1 | M2 |
| Adrenals | 5.85E−02 | 4.10E−02 |
| Brain | 5.10E−04 | 5.91E−04 |
| Breasts | 2.50E−04 | 2.28E−04 |
| Gallbladder wall | 3.42E−03 | 2.43E−03 |
| Lower large intestine wall | 5.65E−04 | 4.40E−04 |
| Small intestine | 9.25E−03 | 2.64E−03 |
| Stomach wall | 5.56E−03 | 2.60E−03 |
| Upper large intestine wall | 1.92E−03 | 1.34E−03 |
| Heart wall | 1.86E−03 | 1.91E−03 |
| Kidneys | 2.40E+00 | 1.66E+00 |
| Liver | 6.56E−03 | 5.10E−03 |
| Lung | 7.81E−03 | 1.22E−02 |
| Muscle | 9.04E−04 | 1.93E−03 |
| Ovaries | 7.36E−04 | 5.33E−04 |
| Pancreas | 1.79E−02 | 5.75E−03 |
| Red marrow | 2.00E−03 | 1.99E−03 |
| Osteogenic cells | 4.83E−03 | 8.45E−03 |
| Skin | 3.92E−04 | 3.17E−04 |
| Spleen | 3.07E−02 | 1.95E−02 |
| Testes | 8.18E−05 | 1.16E−04 |
| Thymus | 2.42E−04 | 2.58E−04 |
| Thyroid | 9.28E-05 | 1.42E−04 |
| Urinary bladder wall | 2.73E−04 | 2.39E−04 |
| Uterus | 3.33E−02 | 5.90E−03 |
| Total body | 1.12E−02 | 8.45E−03 |
Details on M1 and M2 are provided in supplemental data.